Ad
related to: pfizer stock performance 2024 today newsinsights.pfizer.com has been visited by 10K+ users in the past month
Search results
Results From The WOW.Com Content Network
Pharmaceuticals giant Pfizer (NYSE:PFE) reported fourth-quarter and full-year 2024 earnings on Tuesday, Feb. 4, that topped analysts' consensus estimates. The company reported an adjusted earnings ...
*Stock Advisor returns as of February 3, 2025 ... Thank you for joining us today. 2024 was a strong year of execution and performance for Pfizer.
Price Action: PFE stock is down 1.49% at $26.40 at the last check on Tuesday. Read Next: Regeneron Pipeline Aims To Address $220 Billion Therapeutic Opportunities By 2030
Pfizer beat on earnings in the first quarter of 2024, giving its stock a much-needed 7% boost Wednesday.The company reported $14.9 billion in revenue, down 19% compared to last year. That beat ...
The $771 million adjustment to the estimated revenue reversal of $3.5 billion last quarter reflects 1.4 million fewer treatment courses returned by the U.S. government through Feb. 29, 2024 versus ...
Here is whether Pfizer stock might be a buy today -- and why. ... Pfizer grew revenue by 14% year over year in the third quarter of 2024. You can see below that Pfizer's trailing-12 ... In Other News.
Pfizer on Wednesday forecast 2024 sales that could be as much as $5 billion below Wall Street expectations, a move top executives said provided a more reliable view of its COVID-19 business than ...
Pfizer disappointed Wall Street this week with lower revenue guidance for the upcoming year, giving analysts another reason to doubt the company and its stock.Shares for Pfizer were at the end of ...